Please login to the form below

Patient support blog series: Step 3 to a successful patient support programme

In ‘Step 2 to a successful patient support programme’, we discussed the importance of working with internal and external stakeholders to understand everyone’s needs and concerns, so that care plans can be designed to address these.

However, even with insight into the needs of different stakeholders and patients’ adherence challenges, you may not meet your objectives. You won’t necessarily create successful care plans that result in patients taking their medication properly and adhering to it.

The reason? You’re aiming to change people’s existing behaviour and the psychology of human behaviour is complex and context-driven.

Step 3: Key ingredients to successfully change behaviour

Based on over 16 years of experience developing patient support programmes, we recognise five successful ingredients to change behaviour:

  1. Deep insight into how patients think, feel and behave
  2. Health psychology expertise to diagnose the problems and design solutions
  3. A map of possible therapy failure points to ensure appropriate interventions are in place
  4. A consistent approach from the insights, to design and delivery of the programme
  5. The agility to respond to individual needs and change
To read more, please click here.

Alternatively, contact to find out how we can help you.  

25th August 2017



Company Details


Contact Website

Ashfield House
Resolution Road
Ashby de la Zouch
LE65 1HW

Latest content on this profile

Ashfield wins Best Newcomer at the Pf Awards 2018
We are thrilled to announce that Zuchaela Smylie, from Ashfield, won Best Newcomer at the 2018 Pf Awards, the largest pharmaceutical sales awards in the UK. The awards ceremony took place on Thursday, 9 March at The Lancaster Hotel in London.
“It is evident that meeting face-to-face is still highly valued in the digital age”
Attending a scientific congress or meeting overtakes professional journals and publications as the educational channel of choice for Healthcare Professionals – according to findings of new study
Ashfield to present at the Orphan Drugs for Rare Diseases Summit
Ashfield has a breadth of experience with orphan drugs and we are passionate about helping to improve the lives of people living with rare diseases. We are delighted to be sponsoring and presenting at the ‘Orphan Drugs for Rare Diseases’ event 22-23 March in Berlin.
Addressing the biggest challenges for rare disease communities
Each year, Rare Disease Day takes place worldwide on the last day in February. The main objective of Rare Disease Day is to raise awareness amongst the general public, the healthcare industry and decision-makers about rare diseases and their impact on patients' lives.
Humanise is our strategic approach to healthcare communications. It’s based on the need to understand. It looks at the emotions that make us human. It examines the feelings we have as individuals. It defines the behaviours we show as people.
Ashfield launches new commercial model to improve ROI
Ashfield, part of UDG Healthcare, a global leader in providing outsourced healthcare services, has announced the launch of a pioneering new commercial model called The Ashfield Solution.